| Financial Year |
March 31 2023 |
| Monetary Funds |
2,851,980.03 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
21,820,000.00 |
| Accounts Receivable |
130,034,643.50 |
| Advances to Suppliers |
2,026,622.32 |
| Other Receivables |
9,925,262.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,685,160.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,306,385.01 |
| Total Current Assets |
179,650,053.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
204,803.30 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,815,981.89 |
| R&D expenses |
-- |
| Goodwill |
128,006,213.66 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
19,068,651.99 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
150,095,650.84 |
| Total Assets |
329,745,704.67 |
| Short-Term Loans |
4,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
74,583,599.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,071,626.43 |
| Taxes Payable |
13,648,186.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
83,130,439.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
20,521,967.19 |
| Sub-Total of Current Liabilities |
206,761,785.86 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,187,660.08 |
| Deferred Income Tax Liabilities |
371,156.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,558,816.32 |
| Total Liabilities |
212,320,602.18 |
| Paid-In Capital(Or Share Stock) |
91,190,954.00 |
| Capital Surplus |
493,785,070.46 |
| Surplus Reserve |
40,109,318.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-553,976,852.64 |
| Minority Stockholder's Interest |
46,316,611.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
71,108,490.58 |
| Owner's Equity（Stockholder's Equity） |
117,425,102.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
329,745,704.67 |
